Onesource Specialty Pharma Limited: Methohexital Sodium For Injection, Usp 500 Mg Multiple Dose Vial

Recall Summary OneSource Specialty Pharma is recalling Methohexital Sodium for Injection 500 mg multiple-dose vials (NDC 23155-893-31) distributed nationwide because the product failed to meet purity standards—it contains higher levels of impurities or degradation products than allowed. This is a Class II recall, meaning the product could cause serious health problems. The affected medication was manufactured in India for Avet Pharmaceuticals and distributed across all U.S. states and Washington, D.C.

Recalling firm
ONESOURCE SPECIALTY PHARMA LIMITED
Product
Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31
Reason
Failed Impurities/Degradation Specifications
Classification
Class II
Category
drug recall
Country
United States
Agency
U.S. Food and Drug Administration
Recall date
2026-06-07
Status
Ongoing
Areas affected
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
Distribution
Nationwide within the United States

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/18610694-fb61-40d2-b3ad-7d8b2c1261ad